This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1990 Apr 21;335(8695):948-52.

doi: 10.1016/0140-6736(90)91006-v.

Parkinson's disease

Affiliations

PMID: 1691427
DOI: 10.1016/0140-6736(90)91006-v

Review

Parkinson's disease

C D Marsden. Lancet. 1990.

. 1990 Apr 21;335(8695):948-52.

doi: 10.1016/0140-6736(90)91006-v.

Author

Affiliation

¹ University Department of Clinical Neurology, National Hospital for Nervous Diseases, London, UK.

PMID: 1691427
DOI: 10.1016/0140-6736(90)91006-v

No abstract available

PubMed Disclaimer

Similar articles

Hemiparkinsonism and levodopa-induced dyskinesias following focal nigral lesion.
Alves R, Barbosa E, Scaff M. Alves R, et al. Mov Disord. 2006 Dec;21(12):2267-8; author reply 2268. doi: 10.1002/mds.21167. Mov Disord. 2006. PMID: 17078068 No abstract available.
Moderate Parkinson's disease. Strategies for maximizing treatment.
Silverstein PM. Silverstein PM. Postgrad Med. 1996 Jan;99(1):52-4, 61-3, 67-8, passim. Postgrad Med. 1996. PMID: 8539210 Review.
Current controversies: levodopa in the treatment of Parkinson's disease.
Sharma JC, Vassallo M, Ross IN. Sharma JC, et al. Mov Disord. 2005 May;20(5):642-3; author reply 643-4. doi: 10.1002/mds.20444. Mov Disord. 2005. PMID: 15732129 No abstract available.
Current and emerging drug therapies in the management of Parkinson's disease.
Koller WC, Tolosa E. Koller WC, et al. Neurology. 1998 Jun;50(6 Suppl 6):S1. doi: 10.1212/wnl.50.6_suppl_6.s1. Neurology. 1998. PMID: 9633678 No abstract available.
Medical treatment of Parkinson's disease.
Ahlskog JE. Ahlskog JE. Compr Ther. 1989 Mar;15(3):53-9. Compr Ther. 1989. PMID: 2650977 Review. No abstract available.

See all similar articles

Cited by

Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits.
Amano S, Kegelmeyer D, Hong SL. Amano S, et al. Front Syst Neurosci. 2015 Jan 6;8:242. doi: 10.3389/fnsys.2014.00242. eCollection 2014. Front Syst Neurosci. 2015. PMID: 25610377 Free PMC article.
Intraoperative functional MRI as a new approach to monitor deep brain stimulation in Parkinson's disease.
Hesselmann V, Sorger B, Girnus R, Lasek K, Maarouf M, Wedekind C, Bunke J, Schulte O, Krug B, Lackner K, Sturm V. Hesselmann V, et al. Eur Radiol. 2004 Apr;14(4):686-90. doi: 10.1007/s00330-003-2051-0. Epub 2003 Sep 26. Eur Radiol. 2004. PMID: 14513267
Synucleinopathies Take Their Toll: Are TLRs a Way to Go?
Mazzotta GM, Ceccato N, Conte C. Mazzotta GM, et al. Cells. 2023 Apr 24;12(9):1231. doi: 10.3390/cells12091231. Cells. 2023. PMID: 37174631 Free PMC article. Review.
GBA Variants and Parkinson Disease: Mechanisms and Treatments.
Smith L, Schapira AHV. Smith L, et al. Cells. 2022 Apr 8;11(8):1261. doi: 10.3390/cells11081261. Cells. 2022. PMID: 35455941 Free PMC article. Review.
Proteolytic α-Synuclein Cleavage in Health and Disease.
Bluhm A, Schrempel S, von Hörsten S, Schulze A, Roßner S. Bluhm A, et al. Int J Mol Sci. 2021 May 21;22(11):5450. doi: 10.3390/ijms22115450. Int J Mol Sci. 2021. PMID: 34064208 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information